Cancer patients across India are set to receive significant financial relief as revised prices of 1,364 anti-cancer medicine formulations came into effect on November 9. The Department of Pharmaceuticals estimates that the move will generate annual savings of approximately ₹3,540.38 crore for consumers. The price reductions follow the National Pharmaceutical Pricing Continue Reading
